ACELINK THERAPEUTICS

AceLink Therapeutics is a clinical-stage drug development company that leverages deep understanding of glycolipid biology to develop groundbreaking therapies for genetic diseases and kidney diseases... AceLink consists of a seasoned team of drug development professionals, consultants, and advisors with a rich knowledge of glycolipid biology, kidney disease, and drug development. We collaborate with an experienced network of contract research organizations, academics, and key opinion leaders (KOLs). This model allows us to efficiently transform scientific discoveries into impactful new therapies.

Primary location: Newark United States